Wednesday, February 09, 2022 6:11:52 PM
Yost still stole BTH work when he slid to Owlstone. Sucks but BTH couldn't produce a product. ie>NASH>AGN...
Irrelevant?
IPF/CC may hit a couple end-points...
Currently strong support in the UK with top of the line folks involved in the microdose DMT clinical trial. It could progress fast. Maybe...
Cancer research is often for 'possible' terminal patients. There is funding support and continuous research efforts for solutions, especially in the USA.
Seems we've possibly passed the lows after consolidation and folks may look ahead. A fair+ Risk to Reward, IMO.
...GLTA...
* 5M shares @ $.5. Bonuses to BODs included.
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM